Skip to main navigation Skip to search Skip to main content

Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: A prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

  • Antoaneta Tomova
  • , Rupert Bartsch
  • , Thomas Brodowicz
  • , Valentina Tzekova
  • , Constanta Timcheva
  • , Christoph Wiltschke
  • , Dany Abi Gerges
  • , Jan Pawlega
  • , Stanislav Spanik
  • , Moshe Inbar
  • , Christoph C. Zielinski
  • Plovdiv Cancer Centre
  • Medical University of Vienna
  • University Hospital 'Queen Giovanna'
  • National Oncology Center Bulgaria
  • Lebanese American University
  • Jagiellonian University in Kraków
  • Onkol. Ustav Sv. Alzbety
  • Tel Aviv Sourasky Medical Center

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: A prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science